Preventive Measures for COVID-19 and Contact Dermatitis: Clinical Observations
There is growing evidence of the increasing prevalence of allergic and irritant contact dermatitis due to COVID-19 preventive measures, underscoring the importance of dermatological surveillance and skin care strategies in mitigating dermatological complications associated with pandemic-related interventions.
October 2022
Latin America: Mental Health of Healthcare Personnel at Risk
Despite the high prevalence of mental health issues among healthcare personnel in Latin America during the COVID-19 pandemic, only a third of those in need of psychological help received appropriate support, highlighting the urgent need for mental health resources and support services for frontline workers.
October 2022
Neurological Developmental Differences in Infants Born During the COVID-19 Pandemic
Being born during the COVID-19 pandemic is associated with differences in neurological development at 6 months of age, suggesting potential impacts of prenatal and early-life exposures on infant brain development and highlighting the need for further research to understand the long-term consequences.
October 2022
Baricitinib Reduces Mortality in Severe COVID-19: Implications for Treatment
Baricitinib reduces the risk of death when administered to hospitalized patients with severe COVID-19, providing valuable therapeutic options to improve outcomes in critically ill individuals and mitigate the burden of COVID-19 mortality.
September 2022
Long COVID Prediction: Insights from Systems Biology
A study led by the Institute for Systems Biology identifies several warning factors for long COVID, providing insights into the underlying biological mechanisms and informing predictive models for identifying individuals at increased risk of persistent symptoms following SARS-CoV-2 infection.
September 2022
Long-Term Cardiovascular Outcomes of COVID-19: Implications for Follow-Up Care
Individuals with COVID-19 exhibit increased risks of incident cardiovascular disease at 12 months post-infection, highlighting the long-term cardiovascular consequences of SARS-CoV-2 infection and the need for comprehensive follow-up care to mitigate cardiovascular risk factors and prevent adverse outcomes.
September 2022
COVID-19 Restrictions Linked to Fewer Dengue Cases: Insights from Epidemiological Studies
COVID-19 measures, including school closures and restrictions on high-traffic areas, are associated with a significant reduction of 750,000 dengue cases, highlighting the unintended yet beneficial consequences of pandemic-related interventions on vector-borne diseases.
September 2022
Metabolic Syndrome and COVID-19 Outcomes: Implications for Disease Burden
Metabolic syndrome is associated with an increased risk of acute respiratory distress syndrome (ARDS) and death from COVID-19, providing insights into the disproportionate impact of COVID-19 on individuals with metabolic comorbidities and underlying cardiometabolic dysfunction.
September 2022
Paths to Super Immunity for COVID-19: Laboratory Research Insights
New laboratory research reveals multiple paths to robust immunity against COVID-19, providing insights into immune responses and informing vaccine development strategies to enhance protective immunity against emerging SARS-CoV-2 variants.
September 2022
Coronadengue: Syndemic of COVID-19 and Dengue Co-Infection
Coronadengue, the combined infection of COVID-19 and dengue, presents as a syndemic or synergistic epidemic, with the first case detected in Rosario, Argentina in 2022, highlighting the overlapping public health challenges posed by emerging infectious diseases and the need for integrated surveillance and control measures.
September 2022
